HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Emira Ayroldi Selected Research
Emira Ayroldi Research Topics
Disease
11
Neoplasms (Cancer)
12/2023 - 10/2014
4
Autoimmune Diseases (Autoimmune Disease)
01/2022 - 01/2011
3
Inflammation (Inflammations)
12/2023 - 01/2011
3
Hypersensitivity (Allergy)
01/2020 - 02/2006
2
Infections
01/2022 - 10/2014
2
Thyroid Neoplasms (Thyroid Cancer)
09/2020 - 01/2018
1
Immune System Diseases (Immune Disorders)
01/2022
1
Virus Diseases (Viral Diseases)
01/2022
1
Sleep Deprivation
01/2022
1
Glioblastoma (Glioblastoma Multiforme)
01/2022
1
Colitis
01/2020
1
Psoriasis (Pustulosis Palmaris et Plantaris)
01/2011
1
Skin Diseases (Skin Disease)
01/2011
1
Dyslipidemias (Dyslipidemia)
01/2011
1
Atherosclerosis
01/2011
1
Tuberous Sclerosis (Bourneville's Disease)
06/2007
1
Retinoblastoma (Glioblastoma, Retinal)
06/2007
1
Pulmonary Fibrosis (Fibrosing Alveolitis)
02/2006
1
Experimental Arthritis
08/2005
1
Arthritis (Polyarthritis)
08/2005
1
Joint Diseases (Joint Disease)
08/2005
1
Rheumatoid Arthritis
08/2005
Drug/Important Bio-Agent (IBA)
8
Glucocorticoids
IBA
01/2022 - 08/2005
3
Cytokines
IBA
01/2021 - 08/2005
2
Mitogen-Activated Protein Kinases
IBA
09/2020 - 01/2018
2
Proteins (Proteins, Gene)
FDA Link
09/2020 - 01/2018
1
Antioxidants
IBA
12/2023
1
Volatile Oils (Essential Oils)
IBA
12/2023
1
Temozolomide (Temodar)
FDA Link
Generic
01/2022
1
Immunosuppressive Agents (Immunosuppressants)
IBA
01/2022
1
Cyclooxygenase 2 (Cyclooxygenase-2)
IBA
01/2022
1
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
01/2021
1
Type II Tumor Necrosis Factor Receptors
IBA
01/2020
1
fusarubin
IBA
01/2019
1
anhydrofusarubin
IBA
01/2019
1
Naphthoquinones
IBA
01/2019
1
Glucocorticoid Receptors (Glucocorticoid Receptor)
IBA
01/2018
1
Interferons
IBA
11/2017
1
Small Ubiquitin-Related Modifier Proteins (SUMO Proteins)
IBA
11/2017
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2011
1
Interleukin-23 (Interleukin 23)
IBA
01/2011
1
Fats
IBA
01/2011
1
Apolipoproteins
IBA
01/2011
1
Ustekinumab (CNTO 1275)
FDA Link
01/2011
1
Infliximab (Remicade)
FDA Link
01/2011
1
Adalimumab (Humira)
FDA Link
01/2011
1
Peroxisome Proliferator-Activated Receptors (PPAR)
IBA
01/2011
1
Etanercept (Enbrel)
FDA Link
01/2011
1
Sterol Regulatory Element Binding Protein 1
IBA
01/2011
1
Cyclin D1
IBA
06/2007
1
trans-sodium crocetinate (crocetin)
IBA
06/2007
1
Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)
IBA
06/2007
1
Dexamethasone (Maxidex)
FDA Link
Generic
05/2007
1
Ligands
IBA
05/2007
1
Bleomycin (Blenoxane)
FDA Link
Generic
02/2006
1
Collagen Type II (Type II Collagen)
IBA
08/2005
1
Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)
IBA
08/2005
1
Inflammation Mediators
IBA
08/2005
Therapy/Procedure
5
Therapeutics
01/2022 - 01/2011
1
Immunotherapy
01/2021
1
Radiotherapy
01/2018
1
Bone Marrow Transplantation (Transplantation, Bone Marrow)
10/2014